Document is current
Any future updates will be listed below
-
Authors
Feng, Bing
Feng, Xudong
Yu, Yingduo
Xu, Haoying
Ye, Qingqing
Hu, Ruitian
Fang, Xinru
Gao, Feiqiong
Wu, Jian
Pan, Qiaoling
Yu, Jiong
Lang, Guanjing
Li, Lanjuan
Cao, Hongcui https://orcid.org/0000-0002-6604-6867
-
Funding
Funding for this research was provided by:
Fundamental Research Funds for the Central Universities (No. 226-2022-00098, 2022ZFJH003)
Research Project of Jinan Microecological Biomedicine Shandong Laboratory (No: JNL-2022026C)
National Key Research and Development Program of China Stem Cell and Translational Research (2022YFA1105603)
- License Information
-
More Information
Article History
Received: 18 October 2022
Accepted: 31 July 2023
First Online: 8 August 2023
Declarations
:
: Title of the approved project: Study on the mechanisms of EGFP-labeled human placental mesenchymal stem cell transplantation for acute lung injury. Name of the institutional approval committee or unit: The Ethics Committee of The First Affiliated Hospital of Zhejiang University. Approval number: No: 2015-130. Date of approval: February 27, 2015. In addition, all the animal procedures were followed ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.
: Not applicable.
: The authors declare no competing interests.
